Company intelligence / Profile preview

Mianus Capital

New York City, New York, USAlinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

Mianus Capital is an active venture capital firm specializing in early-stage to late-stage investments in innovative healthcare and life science companies globally—especially those focused on ophthalmology—with support from its strategic partnership with MERIT CRO for clinical trial expertise and deal flow.

Therapeutic areas: OncologyOphthalmologyOther
Modalities: Small moleculeBiologicMonoclonal antibodyGene therapy
Industry: Investors

Partnerships

MERIT CRO

Beyond the preview

Go deeper on Mianus Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mianus Capital.

Explore the full profile